A.F. Hofmann

2.4k total citations
44 papers, 1.8k citations indexed

About

A.F. Hofmann is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, A.F. Hofmann has authored 44 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 17 papers in Surgery and 8 papers in Molecular Biology. Recurrent topics in A.F. Hofmann's work include Drug Transport and Resistance Mechanisms (27 papers), Pediatric Hepatobiliary Diseases and Treatments (10 papers) and Metabolism and Genetic Disorders (5 papers). A.F. Hofmann is often cited by papers focused on Drug Transport and Resistance Mechanisms (27 papers), Pediatric Hepatobiliary Diseases and Treatments (10 papers) and Metabolism and Genetic Disorders (5 papers). A.F. Hofmann collaborates with scholars based in United States, Italy and Spain. A.F. Hofmann's co-authors include Devorah Gurantz, M F Laker, Gerald Carlson, Lee R. Hagey, S.F. Phillips, V. S. Chadwick, J. C. Debongnie, Timothy S. Gaginella, R. G. Danzinger and C D Schteingart and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and American Journal of Clinical Nutrition.

In The Last Decade

A.F. Hofmann

44 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.F. Hofmann United States 21 901 718 388 365 233 44 1.8k
W.G.M. Hardison United States 24 570 0.6× 471 0.7× 421 1.1× 271 0.7× 230 1.0× 54 1.5k
R J Vonk Netherlands 22 510 0.6× 415 0.6× 227 0.6× 314 0.9× 212 0.9× 52 1.5k
Dirk Meijer Netherlands 23 676 0.8× 316 0.4× 324 0.8× 493 1.4× 289 1.2× 71 1.9k
K.‐Fr. Sewing Germany 24 434 0.5× 690 1.0× 76 0.2× 666 1.8× 525 2.3× 101 2.3k
Kazumi Yamasaki Japan 16 346 0.4× 284 0.4× 602 1.6× 213 0.6× 61 0.3× 67 1.4k
I. M. Arias United States 26 1.3k 1.5× 541 0.8× 241 0.6× 1.1k 3.0× 968 4.2× 48 2.7k
Warren P. Bishop United States 20 239 0.3× 468 0.7× 91 0.2× 440 1.2× 160 0.7× 75 1.5k
A.R. Tanner United Kingdom 20 213 0.2× 314 0.4× 314 0.8× 168 0.5× 38 0.2× 47 1.3k
Inge A.M. de Graaf Netherlands 24 651 0.7× 261 0.4× 117 0.3× 416 1.1× 135 0.6× 57 1.9k

Countries citing papers authored by A.F. Hofmann

Since Specialization
Citations

This map shows the geographic impact of A.F. Hofmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.F. Hofmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.F. Hofmann more than expected).

Fields of papers citing papers by A.F. Hofmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.F. Hofmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.F. Hofmann. The network helps show where A.F. Hofmann may publish in the future.

Co-authorship network of co-authors of A.F. Hofmann

This figure shows the co-authorship network connecting the top 25 collaborators of A.F. Hofmann. A scholar is included among the top collaborators of A.F. Hofmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.F. Hofmann. A.F. Hofmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lorenzo‐Zúñiga, Vicente, Ramón Bartolí, Ramón Planas, et al.. (2003). Oral Bile Acids Reduce Bacterial Overgrowth, Bacterial Translocation, and Endotoxemia in Cirrhotic Rats. Hepatology. 37(3). 551–557. 265 indexed citations
2.
Hofmann, A.F., et al.. (2002). Cholestatic liver disease: pathophysiology and therapeutic options. Liver International. 22(s2). 14–19. 83 indexed citations
3.
Duane, W C, C D Schteingart, H.-T. Ton-Nu, & A.F. Hofmann. (1996). Validation of [22,23-3H]cholic acid as a stable tracer through conversion to deoxycholic acid in human subjects. Journal of Lipid Research. 37(2). 431–436. 20 indexed citations
4.
Heuman, Douglas M., Z. Reno Vlahčevič, William M. Pandak, et al.. (1992). Effect of cholylsarcosine on hepatic cholesterol and bile acid synthesis and bile secretion in rats. Gastroenterology. 103(5). 1641–1648. 6 indexed citations
5.
Hofmann, A.F., et al.. (1991). Plasma pyridoxal and pyridoxal 5′-phosphate concentrations in response to ingestion of water or glucose polymer during a 2-h run. American Journal of Clinical Nutrition. 53(1). 84–89. 20 indexed citations
6.
Hofmann, A.F., et al.. (1991). Contact Dissolution of Cholesterol Gallstones with Organic Solvents. Gastroenterology Clinics of North America. 20(1). 183–199. 16 indexed citations
7.
Hofmann, A.F.. (1990). Bile acid secretion, bile flow and biliary lipid secretion in humans.. PubMed. 12(3 Pt 2). 17S–22S; discussion 22S. 61 indexed citations
8.
Engelking, Larry R., M. S. Anwer, & A.F. Hofmann. (1989). Basal and bile salt-stimulated bile flow and biliary lipid excretion in ponies. American Journal of Veterinary Research. 50(4). 578–582. 4 indexed citations
9.
Gurantz, Devorah & A.F. Hofmann. (1984). Influence of bile acid structure on bile flow and biliary lipid secretion in the hamster. American Journal of Physiology-Gastrointestinal and Liver Physiology. 247(6). G736–G748. 109 indexed citations
10.
O’Máille, E. R. L., et al.. (1984). Differing effects of norcholate and cholate on bile flow and biliary lipid secretion in the rat. American Journal of Physiology-Gastrointestinal and Liver Physiology. 246(1). G67–G71. 32 indexed citations
11.
Nakagaki, M., R. G. Danzinger, A.F. Hofmann, & Aldo Roda. (1983). Hepatic biotransformation of two hydroxy-7-oxotaurine-conjugated bile acids in the dog. American Journal of Physiology-Gastrointestinal and Liver Physiology. 245(3). G411–G417. 13 indexed citations
12.
René, E, R. G. Danzinger, A.F. Hofmann, & M. Nakagaki. (1983). Pharmacologic effect of somatostatin on bile formation in the dog. Enhanced ductular reabsorption as the major mechanism of anticholeresis.. PubMed. 84(1). 120–9. 43 indexed citations
13.
Zerwekh, Joseph E., John Gregory, David Griffith, et al.. (1983). Assay of urinary oxalate: six methodologies compared.. Clinical Chemistry. 29(11). 1977–1980. 39 indexed citations
14.
Gilmore, Ian, James L. Barnhart, A.F. Hofmann, & Serge Erlinger. (1982). Effects of individual taurine-conjugated bile acids on biliary lipid secretion and sucrose clearance in the unanesthetized dog. American Journal of Physiology-Gastrointestinal and Liver Physiology. 242(1). G40–G46. 16 indexed citations
15.
Gurantz, Devorah, M F Laker, & A.F. Hofmann. (1981). Enzymatic measurement of choline-containing phospholipids in bile.. Journal of Lipid Research. 22(2). 373–376. 163 indexed citations
16.
Hofmann, A.F., et al.. (1981). Hyperoxaluria associated with intestinal bypass surgery for morbid obesity: occurrence, pathogenesis and approaches to treatment.. PubMed. 5(5). 513–8. 13 indexed citations
17.
Thistle, Johnson L., et al.. (1978). Ursodeoxycholic acid unsaturates bile at a lower dose than chenodeoxycholic acid. Gastroenterology. 74(5). 1103–1103. 6 indexed citations
18.
Watkins, J. B., et al.. (1977). 13C-trioctanoin: a nonradioactive breath test to detect fat malabsorption.. PubMed. 90(3). 422–30. 47 indexed citations
19.
Henegouwen, G. P. van Berge & A.F. Hofmann. (1975). Solubility and bio availability of cheno deoxy cholic acid. Gastroenterology. 69(3). 873. 2 indexed citations
20.
Hofmann, A.F.. (1961). Chemical pharmacological and medical aspects of psychotomimetics.. PubMed. 5. 31–51. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026